BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25512613)

  • 1. Stabilization of ATF5 by TAK1-Nemo-like kinase critically regulates the interleukin-1β-stimulated C/EBP signaling pathway.
    Zhang ZY; Li SZ; Zhang HH; Wu QR; Gong J; Liang T; Gao L; Xing NN; Liu WB; Du RL; Zhang XD
    Mol Cell Biol; 2015 Mar; 35(5):778-88. PubMed ID: 25512613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT3 regulates Nemo-like kinase by mediating its interaction with IL-6-stimulated TGFbeta-activated kinase 1 for STAT3 Ser-727 phosphorylation.
    Kojima H; Sasaki T; Ishitani T; Iemura S; Zhao H; Kaneko S; Kunimoto H; Natsume T; Matsumoto K; Nakajima K
    Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4524-9. PubMed ID: 15764709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt-1 signal induces phosphorylation and degradation of c-Myb protein via TAK1, HIPK2, and NLK.
    Kanei-Ishii C; Ninomiya-Tsuji J; Tanikawa J; Nomura T; Ishitani T; Kishida S; Kokura K; Kurahashi T; Ichikawa-Iwata E; Kim Y; Matsumoto K; Ishii S
    Genes Dev; 2004 Apr; 18(7):816-29. PubMed ID: 15082531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heat shock protein 90 (Hsp90) regulates the stability of transforming growth factor beta-activated kinase 1 (TAK1) in interleukin-1beta-induced cell signaling.
    Shi L; Zhang Z; Fang S; Xu J; Liu J; Shen J; Fang F; Luo L; Yin Z
    Mol Immunol; 2009 Feb; 46(4):541-50. PubMed ID: 18950863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The TAK1-NLK-MAPK-related pathway antagonizes signalling between beta-catenin and transcription factor TCF.
    Ishitani T; Ninomiya-Tsuji J; Nagai S; Nishita M; Meneghini M; Barker N; Waterman M; Bowerman B; Clevers H; Shibuya H; Matsumoto K
    Nature; 1999 Jun; 399(6738):798-802. PubMed ID: 10391247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-1 beta induction of matrix metalloproteinase-1 transcription in chondrocytes requires ERK-dependent activation of CCAAT enhancer-binding protein-beta.
    Raymond L; Eck S; Mollmark J; Hays E; Tomek I; Kantor S; Elliott S; Vincenti M
    J Cell Physiol; 2006 Jun; 207(3):683-8. PubMed ID: 16453302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of FOXO1 by TAK1-Nemo-like kinase pathway.
    Kim S; Kim Y; Lee J; Chung J
    J Biol Chem; 2010 Mar; 285(11):8122-9. PubMed ID: 20061393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nemo-like kinase (NLK) negatively regulates NF-kappa B activity through disrupting the interaction of TAK1 with IKKβ.
    Li SZ; Zhang HH; Liang JB; Song Y; Jin BX; Xing NN; Fan GC; Du RL; Zhang XD
    Biochim Biophys Acta; 2014 Jul; 1843(7):1365-72. PubMed ID: 24721172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt activates the Tak1/Nemo-like kinase pathway.
    Smit L; Baas A; Kuipers J; Korswagen H; van de Wetering M; Clevers H
    J Biol Chem; 2004 Apr; 279(17):17232-40. PubMed ID: 14960582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fbxw7 acts as an E3 ubiquitin ligase that targets c-Myb for nemo-like kinase (NLK)-induced degradation.
    Kanei-Ishii C; Nomura T; Takagi T; Watanabe N; Nakayama KI; Ishii S
    J Biol Chem; 2008 Nov; 283(45):30540-8. PubMed ID: 18765672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The TAK1-NLK mitogen-activated protein kinase cascade functions in the Wnt-5a/Ca(2+) pathway to antagonize Wnt/beta-catenin signaling.
    Ishitani T; Kishida S; Hyodo-Miura J; Ueno N; Yasuda J; Waterman M; Shibuya H; Moon RT; Ninomiya-Tsuji J; Matsumoto K
    Mol Cell Biol; 2003 Jan; 23(1):131-9. PubMed ID: 12482967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nemo-like kinase (NLK) acts downstream of Notch/Delta signalling to downregulate TCF during mesoderm induction in the sea urchin embryo.
    Röttinger E; Croce J; Lhomond G; Besnardeau L; Gache C; Lepage T
    Development; 2006 Nov; 133(21):4341-53. PubMed ID: 17038519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of nemo-like kinase is an independent prognostic factor in colorectal cancer.
    Zhang W; He J; Du Y; Gao XH; Liu Y; Liu QZ; Chang WJ; Cao GW; Fu CG
    World J Gastroenterol; 2015 Aug; 21(29):8836-47. PubMed ID: 26269673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nemo-like kinase (NLK) inhibits the progression of NSCLC via negatively modulating WNT signaling pathway.
    Lv L; Wan C; Chen B; Li M; Liu Y; Ni T; Yang Y; Liu Y; Cong X; Mao G; Xue Q
    J Cell Biochem; 2014 Jan; 115(1):81-92. PubMed ID: 23904219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway.
    Ninomiya-Tsuji J; Kishimoto K; Hiyama A; Inoue J; Cao Z; Matsumoto K
    Nature; 1999 Mar; 398(6724):252-6. PubMed ID: 10094049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nemo-like kinase is involved in NGF-induced neurite outgrowth via phosphorylating MAP1B and paxillin.
    Ishitani T; Ishitani S; Matsumoto K; Itoh M
    J Neurochem; 2009 Dec; 111(5):1104-18. PubMed ID: 19840224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of extracellular signal-regulated kinases and CREB/ATF-1 mediate the expression of CCAAT/enhancer binding proteins beta and -delta in preadipocytes.
    Belmonte N; Phillips BW; Massiera F; Villageois P; Wdziekonski B; Saint-Marc P; Nichols J; Aubert J; Saeki K; Yuo A; Narumiya S; Ailhaud G; Dani C
    Mol Endocrinol; 2001 Nov; 15(11):2037-49. PubMed ID: 11682632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 5'-untranslated region regulates ATF5 mRNA stability via nonsense-mediated mRNA decay in response to environmental stress.
    Hatano M; Umemura M; Kimura N; Yamazaki T; Takeda H; Nakano H; Takahashi S; Takahashi Y
    FEBS J; 2013 Sep; 280(18):4693-707. PubMed ID: 23876217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fasting induced up-regulation of activating transcription factor 5 in mouse liver.
    Shimizu YI; Morita M; Ohmi A; Aoyagi S; Ebihara H; Tonaki D; Horino Y; Iijima M; Hirose H; Takahashi S; Takahashi Y
    Life Sci; 2009 Jun; 84(25-26):894-902. PubMed ID: 19376136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cyclin-dependent kinase 2 inhibitor down-regulates interleukin-1beta-mediated induction of cyclooxygenase-2 expression in human lung carcinoma cells.
    Mukhopadhyay P; Ali MA; Nandi A; Carreon P; Choy H; Saha D
    Cancer Res; 2006 Feb; 66(3):1758-66. PubMed ID: 16452236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.